Infectious Disease and Microbiology – Tropheryma whipplei

Overview

Tropheryma whipplei is a Gram-positive, intracellular bacterium responsible for Whipple disease, a rare chronic multisystem infection. The disease classically affects the small intestine, producing diarrhea and malabsorption, but it can also involve the joints, central nervous system, heart, lymph nodes, and other organs.

A particularly important clinical sequence is migratory arthralgia that precedes gastrointestinal symptoms, sometimes by years.

Classification

Genus: Tropheryma

Species: Tropheryma whipplei

Organism: Gram-positive intracellular bacillus

Disease: Whipple disease

The older spelling:

Tropheryma whippelii

has largely been replaced by:

Tropheryma whipplei

Microbiologic Characteristics

T. whipplei is:

• A Gram-positive bacterium

• Intracellular

• Difficult to identify by routine culture

• Associated with chronic infection of macrophages

• Capable of producing multisystem disease

The organism accumulates within macrophages, particularly in the:

Small-intestinal lamina propria

High-Yield Microbiology Pattern

Intracellular Gram-positive bacterium

• ●

PAS-positive macrophages in small intestine

• ●

Migratory arthralgia

• ●

Diarrhea and malabsorption

→ Think TROPHERYMA WHIPPLEI

Incubation Period

The incubation period is:

Unknown

Whipple disease typically follows a:

Chronic, slowly progressive course

rather than a clearly defined acute incubation period.

Epidemiology

T. whipplei probably has a:

Worldwide distribution

Exposure or asymptomatic carriage appears to be more common than clinically apparent Whipple disease.

Actual disease is:

Rare

suggesting that host susceptibility contributes substantially to disease development.

Whipple Disease

The major clinical syndrome is:

WHIPPLE DISEASE

It is a chronic:

Multisystem infectious disease

that classically combines:

Joint symptoms + gastrointestinal disease + systemic manifestations

Classic Clinical Sequence

One of the most characteristic patterns is:

Migratory arthralgia

↓

Months or years later

↓

Diarrhea

• ●

Malabsorption

• ●

Weight loss

This sequence is highly characteristic of:

T. whipplei

Migratory Arthralgia

Joint manifestations are often among the:

Earliest symptoms

Patients may experience:

• Migratory arthralgia

• Intermittent arthritis

• Pain involving multiple joints

Importantly, joint symptoms can precede gastrointestinal disease by:

Several years

High-Yield Early Clue

Recurrent migratory arthralgia for years

↓

Later develops:

Chronic diarrhea + weight loss + malabsorption

→ Think WHIPPLE DISEASE

Gastrointestinal Disease

The small intestine is a major site of infection.

Typical manifestations include:

• Chronic diarrhea

• Steatorrhea

• Abdominal discomfort

• Weight loss

• Malabsorption

Malabsorption

Accumulation of infected macrophages within the intestinal mucosa interferes with:

Normal nutrient absorption

This can result in:

• Weight loss

• Nutritional deficiencies

• Weakness

• Hypoalbuminemia

• Anemia in some patients

Lymphadenopathy

The source identifies:

LYMPHADENOPATHY

as another important manifestation.

Mesenteric and peripheral lymph nodes may become involved as part of the systemic infection.

Fever

Patients may experience:

Intermittent or persistent fever

along with other constitutional symptoms such as:

• Fatigue

• Malaise

• Weight loss

Neurologic Whipple Disease

The central nervous system may be involved.

Possible manifestations include:

• Cognitive changes

• Confusion

• Memory impairment

• Ataxia

• Abnormal eye movements

• Seizures

• Hypothalamic dysfunction

• Other focal or diffuse neurologic abnormalities

Oculomasticatory Myorhythmia

A particularly distinctive neurologic manifestation is:

OCULOMASTICATORY MYORHYTHMIA

This consists of rhythmic movements involving the:

Eyes and masticatory muscles

Although uncommon, it is considered highly suggestive of:

CNS Whipple disease

Cardiac Disease

T. whipplei can also cause:

Endocarditis

An important pattern is:

Blood culture-negative endocarditis

because the organism is difficult to recover using conventional bacterial culture techniques.

High-Yield Cardiac Pattern

Endocarditis

• ●

Repeatedly negative routine blood cultures

• ●

Arthralgia/systemic features

→ Consider T. whipplei

Diagnosis

The source identifies two major diagnostic approaches:

• Histologic examination of intestinal biopsy or lymph node

• PCR

Small-Bowel Biopsy

A classic diagnostic procedure is:

Upper endoscopy with small-intestinal biopsy

particularly from the:

Duodenum or proximal small bowel

PAS-Positive Macrophages

The classic histologic finding is:

PAS-POSITIVE FOAMY MACROPHAGES

within the:

Lamina propria of the small intestine

PAS stands for:

Periodic acid–Schiff

The macrophages contain bacterial material from T. whipplei.

Classic Pathology Pattern

Small-intestinal biopsy

↓

Lamina propria filled with foamy macrophages

↓

PAS-positive intracellular material

→ Think WHIPPLE DISEASE

PCR

Polymerase chain reaction (PCR) can detect T. whipplei DNA.

Depending on the clinical syndrome, testing may involve:

• Intestinal tissue

• Lymph-node tissue

• Cerebrospinal fluid

• Synovial fluid

• Cardiac tissue

• Other appropriate specimens

PCR is particularly useful for:

Confirming the organism in compatible clinical disease

Diagnostic Caution

Detection of T. whipplei DNA at some nonsterile sites does not automatically prove:

Whipple disease

because asymptomatic carriage can occur.

Diagnosis therefore requires correlation between:

Clinical syndrome + histopathology + appropriate molecular testing

Treatment

The source lists:

TRIMETHOPRIM–SULFAMETHOXAZOLE (TMP-SMX)

as the primary treatment.

Whipple disease requires:

Prolonged antimicrobial therapy

because of its systemic nature and potential involvement of sanctuary sites such as the CNS.

Additional Treatment

The source lists:

• Penicillin V

• Chloramphenicol

• Tetracycline

as additional treatment options.

These reflect historical therapeutic approaches.

For modern management, treatment selection needs to consider:

CNS penetration, disease location, relapse risk, and antimicrobial susceptibility/clinical guidance.

CNS Considerations

Even patients without obvious neurologic symptoms may have clinically important concern for:

CNS involvement

Therefore, antimicrobial regimens for classic Whipple disease are generally selected with adequate:

Central nervous system penetration

in mind.

Relapse

Whipple disease can:

Relapse

including after apparently successful therapy.

Relapses may involve the:

Central nervous system

and can occur after gastrointestinal symptoms have improved.

Long-term clinical follow-up is therefore important.

Whipple Disease vs. Celiac Disease

Both may cause:

Diarrhea + malabsorption + weight loss

but:

Whipple Disease

→ T. whipplei infection

→ Migratory arthralgia often precedes GI disease

→ PAS-positive macrophages

→ Lymphadenopathy/fever possible

→ Neurologic or cardiac involvement possible

Celiac Disease

→ Immune-mediated response to gluten

→ Villous atrophy

→ Characteristic celiac serology

→ No intracellular bacterial infection

Whipple Disease vs. Mycobacterium avium Complex

Both can produce macrophage-rich intestinal disease, particularly in the appropriate clinical setting.

Whipple Disease

→ PAS-positive macrophages

→ T. whipplei PCR

→ Migratory arthralgia + malabsorption

→ Acid-fast staining generally negative

Disseminated MAC

→ Acid-fast bacilli within macrophages

→ Particularly associated with advanced cellular immunodeficiency

High-Yield Distinction

PAS-positive + acid-fast negative macrophages

→ Think T. whipplei

Macrophages packed with acid-fast bacilli

→ Think MAC

Whipple Disease vs. Tropical Sprue

Both can cause:

Chronic diarrhea and malabsorption

However:

Whipple Disease

→ Migratory arthralgia

→ PAS-positive macrophages

→ Multisystem disease

→ Neurologic/cardiac involvement

Tropical Sprue

→ Malabsorptive syndrome associated with tropical residence

→ No characteristic PAS-positive macrophages containing T. whipplei

High-Yield Clinical Pattern

Years of migratory arthralgia

• ●

Chronic diarrhea

• ●

Weight loss and malabsorption

• ●

Lymphadenopathy

• ●

PAS-positive foamy macrophages in small-bowel biopsy

→ Think TROPHERYMA WHIPPLEI

High-Yield Extraintestinal Pattern

Culture-negative endocarditis

or

Unexplained neurologic disease

• ●

History of migratory arthralgia

±

GI malabsorption

→ Consider Whipple disease

Exam Essentials

Genus: Tropheryma

Species: T. whipplei

Older spelling: T. whippelii

Organism: Intracellular Gram-positive bacterium

Disease: Whipple disease

Distribution: Probably worldwide

Incubation: Unknown

Classic early manifestation: Migratory arthralgia

Classic GI manifestations: Diarrhea + malabsorption + weight loss

Other manifestations: Fever and lymphadenopathy

Neurologic disease: May occur

Cardiac manifestation: Culture-negative endocarditis

Classic biopsy: PAS-positive foamy macrophages in small-intestinal lamina propria

Molecular diagnosis: PCR

Primary source treatment: TMP-SMX

Other source treatments: Penicillin V, chloramphenicol, tetracycline

Important management issue: Prolonged therapy and attention to CNS disease/relapse

Memory Aid

WHIPPLE = WEIGHT LOSS + HIPS HURT + INTESTINE

Think:

Migratory joint pain

↓

Diarrhea

↓

Malabsorption

↓

Weight loss

↓

PAS-positive macrophages

→ Tropheryma whipplei

Another classic association:

WHIPPLE = PAS-POSITIVE MACROPHAGES

Key clinical pearl: Tropheryma whipplei causes Whipple disease, a chronic multisystem infection classically characterized by migratory arthralgia that may precede diarrhea, weight loss, and malabsorption by years. The classic diagnostic finding is PAS-positive foamy macrophages in the small-intestinal lamina propria, with PCR providing organism-specific confirmation. Neurologic disease and culture-negative endocarditis are important extraintestinal manifestations, and prolonged antimicrobial therapy is required because relapse, particularly involving the CNS, can occur.

Medicine – Motor Neurone Disease (Amyotrophic Lateral Sclerosis)

Motor neurone disease (MND) is a progressive neurodegenerative disorder affecting motor neurones. The term amyotrophic lateral sclerosis (ALS) is often used for the common form in which both upper motor neurones and lower motor neurones are involved.

Although the original note emphasizes anterior horn cells, ALS affects more than just the spinal anterior horn. It also involves corticospinal pathways and motor nuclei in the brainstem, which explains the mixture of UMN, LMN, bulbar, and respiratory features.

1. Main Pathology

The disease causes progressive degeneration of:

Upper motor neurones in the motor cortex and corticospinal tracts.

Lower motor neurones in the anterior horn cells of the spinal cord.

Motor cranial nerve nuclei in the brainstem.

This creates the characteristic combination of:

UMN signs + LMN signs in the same patient.

2. Upper Motor Neurone Signs

Upper motor neurone involvement may cause:

Increased tone or spasticity.

Brisk reflexes.

Clonus.

Extensor plantar responses.

Spastic dysarthria when corticobulbar pathways are involved.

These signs reflect degeneration of descending motor pathways.

3. Lower Motor Neurone Signs

Lower motor neurone involvement produces:

Muscle weakness.

Muscle wasting.

Fasciculations.

Reduced tone in affected muscles.

Reduced reflexes where LMN involvement is severe.

The combination of wasting and fasciculation with brisk reflexes elsewhere is particularly suggestive of MND.

4. Limb Weakness

Weakness is progressive and may begin focally.

The upper limbs are commonly affected, and weakness may be particularly noticeable in the hands.

Patients may report difficulty with:

Buttons.

Writing.

Turning keys.

Opening jars.

Using cutlery.

Progression may then involve other limbs.

5. Hand Wasting

Wasting of the intrinsic hand muscles can be an early and striking feature.

The patient may develop:

Interosseous muscle wasting.

Thenar or hypothenar wasting.

Weak grip.

Loss of fine finger movements.

This reflects lower motor neurone degeneration.

6. Fasciculations

Fasciculations are visible spontaneous contractions of individual motor units.

They may appear as brief twitching under the skin.

Fasciculations are common in MND but are not specific on their own, because benign fasciculations can also occur.

Their significance is much greater when accompanied by:

Progressive weakness + muscle wasting + other UMN or LMN signs.

7. Foot Drop

Weakness of ankle dorsiflexion can produce foot drop.

The patient may develop:

High-stepping gait.

Toe catching.

Frequent tripping.

Foot drop may be an early manifestation when lower motor neurone weakness begins in the distal leg.

8. Bulbar Symptoms

Bulbar involvement occurs when motor neurones controlling speech and swallowing are affected.

Patients may develop:

Dysarthria.

Dysphagia.

Weak cough.

Choking episodes.

Aspiration.

Both bulbar palsy and pseudobulbar palsy features may occur because both LMN and UMN pathways can be involved.

9. Bulbar Palsy Features

Bulbar palsy reflects lower motor neurone involvement of the cranial nerve nuclei or their peripheral fibres.

Typical findings include:

Weak, nasal, or slurred speech.

Dysphagia.

Nasal regurgitation.

Tongue wasting.

Tongue fasciculations.

Reduced bulbar reflexes in some patients.

10. Pseudobulbar Features

Pseudobulbar palsy reflects bilateral upper motor neurone corticobulbar involvement.

Typical findings include:

Spastic or strained dysarthria.

Brisk jaw jerk.

Spastic tongue without prominent fasciculations.

Emotional lability or pseudobulbar affect.

In MND, bulbar and pseudobulbar findings may coexist.

11. Dysphagia and Aspiration

Swallowing impairment is a major clinical problem.

Patients may experience:

Coughing during meals.

Choking.

Weight loss.

Recurrent chest infections.

Aspiration pneumonia.

Progressive dysphagia may require enteral feeding support.

12. Respiratory Muscle Weakness

Respiratory failure is a major cause of morbidity and mortality in MND.

Weakness may involve:

Diaphragm.

Intercostal muscles.

Accessory respiratory muscles.

Patients may develop:

Dyspnoea.

Orthopnoea.

Morning headaches from nocturnal hypoventilation.

Poor sleep.

Daytime somnolence.

Weak cough.

13. No Sensory Signs

A classic feature of MND is the relative preservation of sensation.

Patients generally do not develop prominent:

Numbness.

Loss of vibration sense.

Loss of pain or temperature sensation.

Therefore:

Progressive motor weakness with UMN + LMN signs and no sensory loss strongly suggests MND.

Minor sensory symptoms can occur in real-world practice, but significant objective sensory loss should prompt consideration of alternative diagnoses.

14. Other Functions Often Relatively Preserved

Classically, the following are relatively preserved until late:

Sensation.

Eye movements.

Sphincter function.

However, not every patient fits a perfect textbook pattern.

Some patients can develop cognitive or behavioural changes, particularly in association with frontotemporal dementia.

15. Cognitive and Behavioural Involvement

MND is not always purely motor.

A subset of patients develop:

Executive dysfunction.

Behavioural change.

Language difficulties.

Frontotemporal dementia.

This is especially important because ALS and frontotemporal degeneration can overlap clinically and genetically.

16. Diagnosis

MND is primarily a clinical diagnosis based on progressive motor dysfunction with evidence of both UMN and LMN involvement.

The clinician looks for:

Progression over time.

Spread from one body region to another.

UMN signs.

LMN signs.

Absence of a better alternative diagnosis.

17. Electromyography

EMG is a key supportive investigation.

It can demonstrate widespread active and chronic denervation.

Typical findings may include:

Fibrillation potentials.

Positive sharp waves.

Fasciculation potentials.

Large-amplitude, long-duration motor-unit potentials from reinnervation.

EMG helps confirm LMN involvement even in muscles that may not yet appear weak clinically.

18. Nerve Conduction Studies

Nerve conduction studies are usually performed alongside EMG.

They help distinguish MND from peripheral neuropathies and other disorders.

In classic ALS:

Sensory nerve conduction is usually relatively preserved.

Motor studies may show abnormalities related to axonal loss.

Therefore, the original statement that NCS directly “reveals anterior horn cell damage” is a simplification; EMG is more directly useful for demonstrating denervation, while NCS helps exclude alternative peripheral nerve disease.

19. Other Investigations

Other investigations are mainly used to exclude mimics.

These may include:

MRI of brain and spinal cord.

Blood tests.

Thyroid function.

Vitamin B12.

Autoimmune or infectious testing where appropriate.

The exact investigation depends on the clinical presentation.

20. Important Mimics

Conditions that may resemble MND include:

Cervical myelopathy.

Peripheral neuropathy.

Multifocal motor neuropathy.

Myasthenia gravis.

Myopathies.

Vitamin B12 deficiency.

Structural spinal cord disease.

The absence of sensory loss helps, but imaging and neurophysiology are often required to exclude treatable mimics.

21. Riluzole

Riluzole is a disease-modifying treatment used in ALS.

It reduces glutamatergic neurotransmission and provides a modest survival benefit.

It does not reverse established motor neurone loss but may slow progression modestly.

22. Edaravone

In some healthcare systems and selected patients, edaravone may also be used.

It is thought to reduce oxidative cellular injury.

Eligibility and benefit vary by patient and jurisdiction, so its role is more selective than basic supportive care.

23. Muscle Relaxants

Spasticity may be treated with agents such as:

Baclofen.

Tizanidine.

Other treatments may be considered depending on severity.

The aim is to reduce painful stiffness while avoiding excessive weakness or sedation.

24. Management of Dysphagia

Progressive swallowing difficulty requires careful nutritional assessment.

Management may include:

Diet modification.

Speech and language therapy.

High-calorie nutritional support.

Enteral feeding when oral intake becomes unsafe or inadequate.

25. PEG Feeding

A percutaneous endoscopic gastrostomy, PEG, can provide nutritional support when swallowing is severely impaired.

It may help reduce:

Weight loss.

Dehydration.

Difficulty taking medication.

It does not completely eliminate aspiration risk because saliva and refluxed material can still be aspirated.

Timing is important because the procedure becomes more risky as respiratory function deteriorates.

26. Respiratory Support

The original note lists CPAP, but the more important respiratory support in MND is usually non-invasive ventilation, especially bilevel positive airway pressure.

This is because the major problem is alveolar hypoventilation from respiratory muscle weakness, rather than upper-airway collapse alone.

Therefore:

MND respiratory failure → NIV/BiPAP-type support is typically more relevant than ordinary CPAP.

27. Non-Invasive Ventilation

Non-invasive ventilation can improve:

Nocturnal hypoventilation.

Sleep quality.

Daytime symptoms.

Quality of life.

Survival in appropriately selected patients.

It is one of the most important supportive interventions in progressive respiratory muscle weakness.

28. Tracheostomy Ventilation

Some patients may choose tracheostomy with invasive ventilation.

This can provide long-term respiratory support but involves major implications for:

Communication.

Mobility.

Care requirements.

Quality of life.

Advance-care planning.

These decisions require detailed multidisciplinary discussion.

29. Secretion and Cough Management

Weak cough can lead to retained respiratory secretions.

Management may include:

Physiotherapy.

Mechanical cough-assist devices.

Suction when required.

Treatment of excessive saliva.

These measures reduce respiratory complications.

30. Communication Support

Progressive bulbar and limb weakness may impair speech and writing.

Communication aids may include:

Voice amplification.

Tablet or computer-based communication systems.

Eye-gaze technology.

Speech-generating devices.

Early planning is useful before speech deteriorates severely.

31. Multidisciplinary Team Approach

Management is best coordinated through a multidisciplinary team.

This may include:

Neurology.

Respiratory medicine.

Physiotherapy.

Occupational therapy.

Speech and language therapy.

Dietetic support.

Palliative care.

Psychological and social support.

This approach helps address the wide range of motor, nutritional, respiratory, communication, and psychosocial needs.

32. Prognosis

MND is progressive, but survival varies greatly between patients.

Older teaching sometimes gives:

Approximately 2 years for bulbar-onset disease.

Approximately 4 years for limb-onset disease.

These figures are too rigid to apply to individual patients.

In general, bulbar-onset disease tends to have a poorer prognosis than limb-onset disease, but survival ranges widely from months to many years.

33. Factors Associated with Prognosis

Prognosis depends on several factors, including:

Site of onset.

Age at onset.

Rate of progression.

Respiratory involvement.

Nutritional status.

Cognitive or behavioural involvement.

Response to supportive interventions.

Therefore, individual prognosis cannot be predicted accurately from onset pattern alone.

34. Motor Neurone Disease – Note Form

Disease: progressive neurodegenerative motor-system disorder.

ALS: common MND phenotype involving both UMN and LMN degeneration.

Structures involved: motor cortex/corticospinal tracts + anterior horn cells + motor brainstem nuclei.

UMN signs: spasticity, hyperreflexia, clonus and extensor plantars.

LMN signs: weakness, wasting, fasciculations and reduced reflexes in affected muscles.

Limb pattern: progressive weakness, often involving hands or distal limbs.

Foot drop: may occur from distal leg weakness.

Bulbar LMN signs: nasal/weak speech, tongue wasting/fasciculations, dysphagia.

Pseudobulbar UMN signs: spastic dysarthria, brisk jaw jerk and emotional lability.

Respiratory involvement: progressive respiratory muscle weakness and hypoventilation.

Sensation: usually preserved.

Diagnosis: primarily clinical.

EMG: demonstrates widespread denervation and reinnervation.

Nerve conduction studies: help exclude peripheral neuropathy; sensory conduction is usually relatively preserved.

Riluzole: modest disease-modifying survival benefit.

Spasticity treatment: baclofen, tizanidine or similar agents when appropriate.

Feeding support: PEG may be considered for progressive dysphagia and weight loss.

Respiratory support: non-invasive ventilation, usually bilevel support, is more appropriate than simple CPAP for hypoventilation.

Communication: computer, speech-generating and eye-gaze devices.

Care: multidisciplinary and increasingly palliative/supportive as disease progresses.

35. Characteristic Examination Pattern

A very characteristic examination finding is:

Muscle wasting + fasciculations + brisk reflexes + extensor plantars.

This shows simultaneous:

LMN degeneration → wasting and fasciculations.

and

UMN degeneration → hyperreflexia and extensor plantar responses.

When this occurs with progressive weakness and no significant sensory loss, MND becomes a major diagnostic consideration.

Key Clinical Pattern

Think of ALS/MND as:

Progressive MOTOR disease with BOTH UMN and LMN signs, but little or no sensory loss.

The classic pattern is:

Weakness + wasting + fasciculations + hyperreflexia/spasticity + extensor plantars.

Bulbar disease causes:

Dysarthria + dysphagia + aspiration risk.

Respiratory involvement causes:

Progressive hypoventilation and respiratory failure.

For treatment, remember:

Riluzole + symptom control + nutrition/PEG + non-invasive ventilation + communication support + multidisciplinary care.

And one important correction:

Respiratory muscle weakness in MND is usually managed with non-invasive bilevel ventilation rather than standard CPAP.

Medicine – Spastic Paraparesis

Spastic paraparesis means weakness of both lower limbs caused by an upper motor neurone lesion, usually affecting the corticospinal tracts in the spinal cord or, less commonly, bilateral cerebral motor pathways. The legs are weak and stiff, with increased tone and other pyramidal signs.

An asterisk (*) signifies a common cause.

1. Increased Tone

The characteristic motor abnormality is spasticity, meaning increased muscle tone that is velocity-dependent.

On examination, the legs may feel stiff when moved passively.

The increase in tone is usually more marked in the antigravity muscle groups.

2. Clonus

Clonus is a series of rhythmic involuntary muscle contractions triggered by sudden stretching of a muscle.

It is a sign of an upper motor neurone lesion.

A common example is:

Ankle clonus.

Sustained clonus strongly supports significant corticospinal tract dysfunction.

3. Weakness

Patients have weakness affecting both lower limbs.

The pattern depends on the level and severity of the lesion, but the weakness is usually accompanied by:

Spasticity.

Hyperreflexia.

Extensor plantar responses.

The legs may become stiff and difficult to move despite relatively preserved muscle bulk early in the disease.

4. Extensor Plantar Responses

An extensor plantar response, or positive Babinski sign, is an important pyramidal sign.

When the lateral sole is stimulated, the great toe extends upward and the other toes may fan.

Therefore:

Spastic paraparesis + extensor plantars → corticospinal tract involvement.

5. Hyperreflexia

Although not explicitly listed in the original notes, brisk deep tendon reflexes are usually expected in a pure upper motor neurone spastic paraparesis.

Typical findings include:

Brisk knee jerks.

Brisk ankle jerks.

Clonus.

However, reflexes may be reduced if a condition also damages peripheral nerves, such as subacute combined degeneration or Friedreich ataxia.

6. Atrophy and Contractures

Muscle wasting is not usually a prominent early feature of a pure upper motor neurone lesion.

However, chronic severe weakness and immobility may cause:

Disuse atrophy.

Muscle shortening.

Joint contractures.

Therefore, atrophy and contractures are generally late secondary changes, rather than primary features of corticospinal tract disease.

7. Gait

Patients may develop a characteristic spastic gait.

Features may include:

Stiff-legged walking.

Reduced knee flexion.

Scissoring of the legs in severe bilateral spasticity.

Difficulty lifting the feet.

Slow, effortful walking.

The exact gait varies with the underlying cause.

8. Multiple Sclerosis*

Multiple sclerosis is an important cause of spastic paraparesis, especially in younger adults.

Demyelinating plaques involving the spinal cord corticospinal tracts may produce:

Bilateral leg weakness.

Spasticity.

Hyperreflexia.

Extensor plantar responses.

Other MS manifestations may coexist, such as optic neuritis, sensory symptoms, bladder dysfunction, diplopia, or ataxia.

9. Cerebral Palsy*

Cerebral palsy can produce chronic spastic paraparesis when bilateral motor pathways controlling the lower limbs are affected.

A classic form is spastic diplegia, in which:

Both legs are more affected than the arms.

The patient may have:

Increased tone.

Scissoring gait.

Contractures.

Delayed motor development.

This is a non-progressive brain injury, although the musculoskeletal consequences can change over time.

10. Spinal Cord Compression*

Spinal cord compression is one of the most important causes of acquired spastic paraparesis.

Compression damages the corticospinal tracts and may also affect sensory and autonomic pathways.

Clinical features may include:

Back or neck pain.

Spastic leg weakness.

Sensory level.

Bladder or bowel dysfunction.

Hyperreflexia and extensor plantars.

Depending on the cause and progression, spinal cord compression may require urgent investigation.

11. Cervical or Thoracic Spondylosis

Spondylosis refers to degenerative changes of the spine.

When these changes narrow the spinal canal and compress the spinal cord, they may produce degenerative cervical myelopathy or, less commonly, thoracic cord compression.

The patient may develop:

Spastic leg weakness.

Gait difficulty.

Hand clumsiness if the cervical cord is involved.

Brisk reflexes.

Extensor plantar responses.

12. Neoplasia

Tumours can cause spastic paraparesis through compression or infiltration of the spinal cord.

Possible causes include:

Metastatic vertebral disease.

Epidural tumour.

Primary spinal tumour.

Intramedullary tumour.

A history of cancer together with new back pain and progressive leg weakness should raise concern for metastatic spinal cord compression.

13. Disc Prolapse

A large intervertebral disc prolapse may compress the spinal cord if it occurs at a level where the spinal cord is present, particularly in the cervical or thoracic spine.

This can produce:

Spastic paraparesis below the lesion.

By contrast, a lumbar disc prolapse below the conus more commonly compresses nerve roots and causes cauda equina or radicular LMN signs rather than spastic paraparesis.

14. Motor Neurone Disease

Motor neurone disease, particularly amyotrophic lateral sclerosis, can cause a mixture of upper and lower motor neurone findings.

If corticospinal tract involvement is prominent in the lower limbs, the patient may develop:

Spastic paraparesis.

However, additional findings such as:

Muscle wasting.

Fasciculations.

Bulbar weakness.

may suggest combined LMN involvement.

15. Spinal Cord Infarction

Spinal cord infarction may cause sudden or rapidly developing bilateral leg weakness.

The clinical pattern depends on which vascular territory is affected.

Anterior spinal artery infarction may produce:

Motor weakness.

Loss of pain and temperature below the lesion.

with relative preservation of:

Vibration and proprioception, at least initially.

Spasticity may develop after the acute spinal shock phase.

16. Vasculitis

Systemic or central nervous system vasculitis can damage the spinal cord through inflammatory vascular injury and ischaemia.

This may produce a myelopathy with:

Spastic paraparesis.

Sensory abnormalities.

Sphincter dysfunction.

Other systemic inflammatory features may provide clues to the diagnosis.

17. Myelitis

Myelitis means inflammation of the spinal cord.

A common clinical syndrome is transverse myelitis.

Patients may develop:

Bilateral weakness.

Sensory level.

Bladder or bowel dysfunction.

Initially reduced reflexes in spinal shock, followed later by spasticity and hyperreflexia.

Causes include autoimmune disease, infection, demyelinating disease, and idiopathic inflammatory myelopathy.

18. Subacute Combined Degeneration

Subacute combined degeneration due to vitamin B12 deficiency affects the:

Dorsal columns.

Corticospinal tracts.

Peripheral nerves.

It can therefore produce:

Spastic paraparesis.

Sensory ataxia.

Loss of vibration and proprioception.

Peripheral neuropathy.

Extensor plantar responses.

Reflexes may paradoxically be reduced because of simultaneous peripheral nerve damage.

19. Friedreich Ataxia

Friedreich ataxia can also produce pyramidal tract involvement and spastic weakness of the legs.

However, the clinical picture is mixed and usually includes:

Progressive ataxia.

Peripheral sensory neuropathy.

Pes cavus.

Kyphoscoliosis.

Absent tendon reflexes.

Extensor plantar responses.

Cardiomyopathy.

Therefore, it is not a simple pure spastic paraparesis.

20. Syringomyelia

Syringomyelia is formation of a fluid-filled cavity, or syrinx, within the spinal cord.

Classically, it causes:

Loss of pain and temperature in a cape-like distribution.

Preserved vibration and proprioception early.

Lower motor neurone weakness at the level of the lesion.

If the syrinx expands and damages corticospinal tracts, it can eventually produce:

Spastic weakness of the legs below the lesion.

21. Syphilis

Neurosyphilis can affect the spinal cord in several ways.

The classic form tabes dorsalis primarily damages the dorsal columns and dorsal roots, producing sensory ataxia and reduced reflexes rather than a typical spastic paraparesis.

However, other syphilitic forms, such as meningovascular or meningomyelitic disease, can involve corticospinal pathways and cause spastic weakness.

Therefore, syphilis is a less common and more context-dependent cause.

22. Spastic Paraparesis – Note Form

Definition: bilateral lower-limb weakness with upper motor neurone signs.

Tone: increased.

Reflexes: usually brisk.

Clonus: may be present.

Plantar responses: extensor.

Weakness: both legs.

Atrophy: usually secondary to chronic disuse rather than an early primary feature.

Contractures: may develop in chronic severe spasticity.

*Common demyelinating cause: ** multiple sclerosis.

*Common developmental cause: ** cerebral palsy, especially spastic diplegia.

*Common structural cause: ** spinal cord compression.

Cord compression causes: spondylosis, tumour and disc prolapse.

Other causes: motor neurone disease, spinal cord infarction, vasculitis, myelitis, subacute combined degeneration, Friedreich ataxia, syringomyelia and neurosyphilis.

23. Useful Localisation Clues

Spastic paraparesis + sensory level → spinal cord lesion likely.

Spastic paraparesis + bladder dysfunction → spinal cord disease particularly important.

Spastic paraparesis + optic neuritis/other disseminated neurological episodes → consider MS.

Spastic paraparesis + loss of vibration/proprioception + neuropathy → consider vitamin B12 deficiency.

Spastic paraparesis + ataxia + pes cavus + cardiomyopathy → consider Friedreich ataxia.

Spastic paraparesis + cape-like pain/temperature loss → consider syringomyelia.

Key Clinical Pattern

Think of spastic paraparesis as:

Bilateral leg weakness + increased tone + hyperreflexia/clonus + extensor plantar responses.

The major categories are:

Demyelinating → MS.

Developmental → cerebral palsy.

Compressive → spondylosis, tumour, disc disease.

Inflammatory/vascular → myelitis, vasculitis, spinal cord infarction.

Metabolic/hereditary → B12 deficiency, Friedreich ataxia.

A particularly important clinical rule is:

Spastic paraparesis with a sensory level or new bladder/bowel dysfunction should prompt urgent consideration of spinal cord compression or another myelopathy.

Medicine – Subacute Combined Degeneration of the Spinal Cord

Subacute combined degeneration of the spinal cord is a neurological complication most commonly caused by vitamin B12 deficiency. It affects multiple neurological pathways at the same time, particularly the dorsal columns and corticospinal tracts, and is often accompanied by peripheral neuropathy.

The term combined degeneration refers to simultaneous involvement of more than one major spinal cord pathway.

1. Main Cause

The classic cause is:

Vitamin B12 deficiency.

Vitamin B12 is essential for normal myelin maintenance and nervous-system function.

Deficiency can lead to progressive demyelination and axonal injury involving the spinal cord and peripheral nerves.

2. Common Causes of Vitamin B12 Deficiency

Important causes include:

Pernicious anaemia.

Malabsorption, including terminal ileal disease.

Previous gastric or ileal surgery.

Strict vegan diet without adequate supplementation.

Certain medications, such as long-term metformin or acid-suppressing therapy in some patients.

Nitrous oxide exposure, which can functionally inactivate vitamin B12.

3. Pathways Affected

The major neurological structures affected are:

Dorsal columns.

Lateral corticospinal tracts.

Peripheral nerves.

This combination explains the apparently mixed neurological findings.

4. Dorsal Column Involvement

The dorsal columns carry:

Vibration sensation.

Joint-position sense.

Fine discriminative touch.

Damage therefore causes loss of proprioceptive input from the limbs.

The patient may become unsteady, particularly when visual compensation is removed.

5. Sensory Ataxia

Loss of proprioception from dorsal-column disease produces sensory ataxia.

Patients may describe:

Unsteady walking.

Difficulty walking in the dark.

A feeling that they do not know where their feet are.

Examination may show:

Loss of vibration sense.

Loss of joint-position sense.

Positive Romberg test.

6. Positive Romberg Test

A patient with sensory ataxia may maintain balance while the eyes are open because vision compensates for impaired proprioception.

When the eyes are closed, this visual compensation is removed and the patient becomes markedly more unstable.

Therefore:

Dorsal-column disease → sensory ataxia → positive Romberg sign.

7. Peripheral Neuropathy

Vitamin B12 deficiency can also damage peripheral nerves.

This often causes symmetrical distal sensory symptoms in a:

Glove-and-stocking distribution.

Patients may develop:

Numbness.

Tingling.

Burning or altered sensation.

Distal weakness in more advanced disease.

8. Glove-and-Stocking Sensory Loss

A glove-and-stocking pattern means that sensory loss begins distally in the:

Feet and lower legs.

and later, if more severe, the:

Hands.

This pattern reflects a length-dependent peripheral neuropathy rather than isolated spinal cord disease.

9. Corticospinal Tract Involvement

The lateral corticospinal tracts carry upper motor neurone motor fibres.

Damage can therefore produce:

Spasticity.

Increased muscle tone.

Weakness of the legs.

Extensor plantar responses.

The lower limbs are commonly affected more prominently than the upper limbs.

10. Spastic Paraparesis

Bilateral corticospinal tract involvement may cause spastic paraparesis.

This means:

Weakness of both legs + increased tone + pyramidal signs.

Patients may develop a stiff, difficult gait as the disease progresses.

11. Absent Reflexes

One of the characteristic features of subacute combined degeneration is that tendon reflexes may be reduced or absent, especially at the ankles.

This occurs because of the accompanying peripheral neuropathy.

Therefore, even though corticospinal tract disease usually increases reflexes, peripheral nerve damage can reduce the reflex arc.

12. Extensor Plantar Responses

The plantar responses may be extensor, or Babinski positive.

This reflects corticospinal tract involvement.

Thus a classic apparently paradoxical combination may occur:

Absent ankle reflexes + extensor plantar responses.

13. Why Absent Reflexes and Extensor Plantars Can Coexist

These findings arise from damage at different levels.

Peripheral neuropathy → reduced/absent tendon reflexes.

Corticospinal tract damage → extensor plantar responses.

Therefore, the combination does not contradict itself.

It is actually a useful clue to a disorder affecting both peripheral nerves and central motor pathways.

14. Other Neurological Features

Additional manifestations of vitamin B12 deficiency can include:

Weakness.

Paraesthesia.

Gait disturbance.

Cognitive changes.

Mood disturbance.

Optic neuropathy in some cases.

Severe untreated deficiency can lead to permanent neurological damage.

15. Haematological Features

Vitamin B12 deficiency may also cause:

Macrocytic anaemia.

Macro-ovalocytes.

Hypersegmented neutrophils.

However, important neurological disease can occur even when anaemia is mild or absent.

Therefore:

Normal haemoglobin does not exclude neurological vitamin B12 deficiency.

16. Investigations

Useful investigations include:

Serum vitamin B12.

Full blood count and MCV.

Blood film.

Methylmalonic acid, which often rises in B12 deficiency.

Homocysteine, which may also be elevated.

Further testing should investigate the underlying cause, such as pernicious anaemia or malabsorption.

17. Pernicious Anaemia

Pernicious anaemia is an autoimmune cause of vitamin B12 deficiency.

Autoimmune destruction of gastric parietal cells leads to reduced intrinsic factor, impairing absorption of vitamin B12 in the terminal ileum.

Testing may include:

Intrinsic-factor antibodies.

Other autoimmune gastric markers may also support the diagnosis.

18. Treatment

Treatment requires vitamin B12 replacement.

When neurological involvement is present, treatment should not be delayed unnecessarily because prolonged deficiency may cause irreversible deficits.

Replacement is often given parenterally initially, depending on the cause and severity of deficiency.

The underlying cause should also be identified and treated where possible.

19. Important Folate Warning

Folate can improve the anaemia caused by vitamin B12 deficiency without correcting the neurological injury.

Therefore, giving folate alone to someone with unrecognised B12 deficiency may allow neurological disease to continue.

For this reason:

Vitamin B12 deficiency should be excluded or treated when clinically suspected before relying on folate replacement alone.

20. Subacute Combined Degeneration – Note Form

Cause: vitamin B12 deficiency.

Main spinal pathways affected: dorsal columns + corticospinal tracts.

Additional involvement: peripheral nerves.

Dorsal-column damage: loss of vibration and joint-position sense.

Clinical result: sensory ataxia and positive Romberg test.

Peripheral neuropathy: glove-and-stocking sensory loss.

Corticospinal damage: spastic paraparesis and extensor plantar responses.

Reflexes: may be absent because peripheral neuropathy interrupts the reflex arc.

Characteristic mixed pattern: absent reflexes + extensor plantars.

21. Characteristic Examination Pattern

A typical neurological examination may show:

Loss of vibration and proprioception.

Sensory ataxia.

Positive Romberg sign.

Distal glove-and-stocking sensory loss.

Spastic weakness of both legs.

Reduced or absent ankle reflexes.

Extensor plantar responses.

This combination strongly suggests simultaneous involvement of dorsal columns, peripheral nerves and corticospinal tracts.

Key Clinical Pattern

Think of subacute combined degeneration as:

Vitamin B12 deficiency → DORSAL COLUMNS + CORTICOSPINAL TRACTS + PERIPHERAL NERVES.

Therefore:

Dorsal columns → sensory ataxia + loss of vibration/proprioception.

Peripheral nerves → glove-and-stocking neuropathy + absent reflexes.

Corticospinal tracts → spastic paraparesis + extensor plantars.

The high-yield combination is:

Sensory ataxia + peripheral neuropathy + spastic paraparesis + absent reflexes + extensor plantar responses.

Medicine – Cauda Equina Lesions

Cauda equina lesions result from compression or damage to the bundle of lumbosacral nerve roots below the termination of the spinal cord. The cauda equina contains nerve roots that supply the lower limbs as well as sensory and autonomic fibres controlling the bladder, bowel, and sexual function.

Severe compression produces cauda equina syndrome (CES), which is a neurological and spinal surgical emergency because delayed decompression may result in permanent weakness, sensory loss, and bladder or bowel dysfunction.

1. Anatomy of the Cauda Equina

In adults, the spinal cord usually terminates around the L1–L2 vertebral level as the conus medullaris.

Below this level, the lumbar, sacral, and coccygeal nerve roots descend within the spinal canal before leaving through their respective foramina.

This collection of nerve roots resembles a horse’s tail and is therefore called the:

Cauda equina.

2. Nature of the Neurological Lesion

The cauda equina consists of peripheral nerve roots, so damage generally produces lower motor neurone-type abnormalities rather than the upper motor neurone signs expected from spinal cord compression.

Patients may therefore develop:

Flaccid weakness.

Reduced muscle tone.

Reduced or absent tendon reflexes.

Muscle weakness in a nerve-root distribution.

However, the exact findings depend on which roots are compressed.

3. Bilateral Leg Weakness

Cauda equina compression can produce weakness of both lower limbs.

The weakness may be asymmetric, especially early in the disease, because individual nerve roots can be affected to different degrees.

Therefore, although bilateral weakness is characteristic of extensive cauda equina compression:

Cauda equina weakness does not have to be perfectly symmetrical.

4. Weakness Most Marked at the Ankles

Weakness may be particularly prominent distally because the lower lumbar and sacral nerve roots supplying the ankle and foot can be heavily affected.

Patients may have difficulty with:

Ankle dorsiflexion.

Ankle plantarflexion.

Toe movements.

This may produce:

Foot drop.

Difficulty walking on the heels.

Difficulty walking on the toes.

The exact pattern depends on the affected nerve roots.

5. Sensory Loss and Numbness

Patients frequently develop numbness, tingling, or reduced sensation in the lower limbs.

Because multiple nerve roots may be involved, sensory abnormalities can occur in several dermatomes rather than following a single peripheral nerve.

One of the most important patterns is sensory loss in the sacral distribution.

6. Saddle Anaesthesia

Compression of the lower sacral roots can cause sensory loss around the:

Perineum.

Perianal region.

Genital region.

Inner thighs.

This distribution corresponds approximately to the area that would contact a saddle and is therefore called:

Saddle anaesthesia.

This is a major warning sign of cauda equina syndrome.

7. Sacral Sensory Loss

The original description that sensory loss is most marked in the sacral region refers particularly to involvement of the sacral nerve roots.

Patients should be asked specifically about:

Numbness around the anus.

Altered sensation when wiping after using the toilet.

Perineal or genital numbness.

These symptoms can be more clinically important than ordinary leg numbness.

8. Loss of Bladder Control

Damage to the sacral autonomic roots can interfere with bladder function.

A particularly concerning feature is:

Difficulty initiating urination or urinary retention.

The patient may lose the normal sensation of bladder filling.

As retention progresses, an overfilled bladder may eventually produce overflow urinary incontinence.

Therefore, urinary dysfunction in cauda equina syndrome is not simply incontinence.

A particularly important progression is:

Reduced bladder sensation → difficulty voiding → urinary retention → overflow incontinence.

9. Bowel Dysfunction

Sacral nerve-root compression can also interfere with bowel control.

Patients may develop:

Reduced sensation of rectal fullness.

Constipation.

Reduced anal sphincter control.

Faecal incontinence in severe disease.

These findings suggest significant sacral nerve-root dysfunction.

10. Sexual Dysfunction

The sacral nerve roots also participate in sexual function.

Cauda equina syndrome may therefore produce:

Erectile dysfunction.

Reduced genital sensation.

Other disturbances of sexual function.

This can provide another clue to sacral nerve-root involvement.

11. Lower Motor Neurone Signs

Because the cauda equina consists of nerve roots rather than spinal cord tissue, the affected legs may demonstrate:

Reduced tone.

Reduced or absent reflexes.

Flaccid weakness.

For example, involvement of the S1 nerve roots may reduce or abolish the ankle jerk.

12. Radicular Pain

Severe low-back pain with radicular leg pain commonly accompanies cauda equina compression.

Pain may radiate down one or both legs according to the affected nerve roots.

However, absence of severe pain does not completely exclude cauda equina syndrome.

13. Central Lumbar Disc Prolapse

A large central lumbar intervertebral disc prolapse is one of the most important causes of acute cauda equina syndrome.

A small posterolateral disc prolapse may compress only one nerve root and cause ordinary sciatica.

In contrast, a sufficiently large central disc prolapse can compress multiple cauda equina roots simultaneously.

Therefore:

Large central lumbar disc prolapse → multiple root compression → cauda equina syndrome.

14. Degenerative Spondylolisthesis

The original note uses the term spondylolithiasis, but the appropriate term here is usually spondylolisthesis.

Spondylolisthesis means displacement of one vertebra relative to another.

Degenerative changes can narrow the spinal canal and compress the cauda equina, particularly when associated with spinal stenosis.

15. Tumours

Tumours can cause cauda equina syndrome by compressing the lumbosacral nerve roots.

Compression may result from:

Metastatic disease.

Primary spinal tumours.

Tumours involving vertebral structures.

Epidural masses.

Tumours arising around the nerve roots.

Therefore, the important concept is mechanical compression of the cauda equina, rather than assuming that all tumours are necessarily external to the spinal canal.

16. Spinal Stenosis

Lumbar spinal stenosis is narrowing of the spinal canal, commonly due to degenerative changes.

Causes of narrowing may include:

Facet-joint hypertrophy.

Ligamentous thickening.

Disc degeneration or bulging.

Spondylolisthesis.

Severe stenosis can compress multiple cauda equina nerve roots.

Chronic lumbar stenosis more commonly causes neurogenic claudication, but severe compression can occasionally produce cauda equina syndrome.

17. Other Important Causes

Although not included in the original list, other clinically important causes include:

Spinal epidural abscess.

Spinal epidural haematoma.

Severe spinal trauma.

Postoperative or procedural complications.

These are important because some can produce rapidly progressive compression requiring emergency treatment.

18. Red-Flag Symptoms

The combination of back or radicular pain with new neurological abnormalities should raise concern for cauda equina syndrome.

Particularly important red flags are:

New urinary retention or impaired bladder sensation.

Saddle or perineal sensory loss.

New bowel dysfunction.

Bilateral or progressive leg weakness.

Sexual dysfunction.

These findings require urgent assessment.

19. Investigation

When cauda equina syndrome is suspected, the key investigation is generally an urgent MRI of the lumbosacral spine.

MRI can identify:

Large disc prolapse.

Spinal stenosis.

Tumour.

Epidural abscess or haematoma.

Other compressive lesions.

Bladder assessment, including measurement of post-void residual volume, can provide useful additional information but does not replace appropriate neurological assessment and imaging.

20. Treatment

Management depends on the underlying cause, but compressive cauda equina syndrome generally requires urgent specialist spinal assessment and decompression when indicated.

Examples include:

Surgical decompression of a large disc prolapse.

Treatment of spinal tumour compression.

Drainage and antimicrobial therapy for an epidural abscess.

Management of an epidural haematoma.

The aim is to relieve nerve-root compression before irreversible neurological damage develops.

21. Cauda Equina Lesions – Note Form

Site: lumbosacral nerve roots below the spinal cord.

Motor: bilateral or asymmetric lower-limb weakness.

Type of weakness: lower motor neurone pattern.

Distal weakness: may be prominent at the ankles and feet.

Reflexes: reduced or absent depending on the affected roots.

Sensation: lower-limb numbness with important sacral/perineal sensory loss.

Classic sensory sign: saddle anaesthesia.

Bladder: impaired bladder sensation and urinary retention are particularly important.

Late bladder manifestation: overflow incontinence may occur.

Bowel: impaired bowel sensation/control ± faecal incontinence.

Sexual function: may be impaired.

Disc cause: large central lumbar disc prolapse.

Degenerative cause: lumbar spinal stenosis ± degenerative spondylolisthesis.

Tumour: may compress the cauda equina.

Other emergencies: epidural abscess, epidural haematoma and major trauma.

22. Cauda Equina Syndrome versus Simple Sciatica

Simple radiculopathy/sciatica usually involves one or a small number of nerve roots and commonly produces unilateral radicular pain ± focal weakness or sensory loss.

In contrast, cauda equina syndrome involves multiple lumbosacral roots and may produce:

Saddle anaesthesia + bladder/bowel dysfunction + bilateral or progressive neurological deficits.

These autonomic and sacral sensory findings make cauda equina syndrome much more concerning.

Key Clinical Pattern

Think of cauda equina syndrome as:

Multiple lumbosacral nerve-root compression → LMN leg weakness + saddle anaesthesia + sphincter/autonomic dysfunction.

The classic high-yield combination is:

Back/radicular pain + bilateral or progressive leg weakness + saddle anaesthesia + urinary dysfunction.

Important causes are:

Large central lumbar disc prolapse + severe spinal stenosis/spondylolisthesis + tumour + epidural abscess or haematoma.

Most importantly:

New urinary retention or impaired bladder sensation with saddle anaesthesia is an emergency pattern requiring urgent assessment for cauda equina compression.

Infectious Disease and Microbiology – Trichostrongylus Species

Overview

Trichostrongylus species are nematode helminths that primarily infect herbivorous animals but can occasionally infect humans. Human infection is generally acquired in rural settings where livestock are raised and environmental contamination with animal feces occurs.

Most infections are asymptomatic, but heavier worm burdens can produce mild gastrointestinal symptoms and sometimes anemia.

Classification

Genus: Trichostrongylus

Important species include:

• Trichostrongylus orientalis

• Trichostrongylus colubriformis

Organism: Nematode helminth

Microbiologic Characteristics

Trichostrongylus species are:

• Intestinal nematodes

• Parasites commonly associated with herbivorous animals

• Zoonotic helminths capable of infecting humans

• Organisms whose eggs may resemble hookworm eggs on stool microscopy

High-Yield Microbiology Pattern

Nematode

• ●

Rural livestock exposure

• ●

Mild GI symptoms or anemia

• ●

Large hookworm-like eggs in stool

→ Think TRICHOSTRONGYLUS

Incubation Period

The incubation period is:

Unclear

Clinical manifestations depend more on:

Worm burden and host factors

than on a precisely defined incubation interval.

Epidemiology

Trichostrongylus species have a:

Worldwide distribution

Human infection is more common in:

Rural agricultural communities

especially where:

• Sheep are raised

• Goats are raised

• Cattle or other herbivores are present

• Animal feces contaminate soil or vegetation

Reservoir

The major reservoirs are:

Herbivorous animals

including livestock.

Humans are:

Accidental hosts

rather than the principal reservoir.

Transmission

Human infection occurs after ingestion of:

Infective larvae from contaminated food or vegetation

The environmental cycle is maintained when animal feces contaminate:

Soil and plants

High-Yield Exposure Pattern

Rural area

• ●

Livestock/herbivore exposure

• ●

Contaminated raw vegetables

→ Possible Trichostrongylus infection

Life Cycle

Eggs are passed in the feces of infected animals.

↓

Larvae develop in the environment.

↓

Infective larvae contaminate:

Soil, grass, or vegetables

↓

Humans accidentally ingest the larvae.

↓

Adult worms develop in the:

Small intestine

↓

Eggs are eventually passed in human stool.

Clinical Infection

Most infections are:

ASYMPTOMATIC

especially when the parasite burden is low.

Gastrointestinal Manifestations

Symptomatic patients may develop:

• Dyspepsia

• Abdominal discomfort

• Nausea

• Diarrhea

• Reduced appetite

These symptoms are generally:

Mild

Anemia

The source notes that infection may occasionally cause:

ANEMIA

particularly with heavier parasite burdens.

The anemia tends to reflect intestinal parasitism and chronic nutritional or blood-loss effects.

Eosinophilia

As with many tissue or intestinal helminth infections, some patients may develop:

Peripheral eosinophilia

although this is not the defining diagnostic feature.

High-Yield Clinical Pattern

Rural livestock exposure

• ●

Mild abdominal symptoms

• ●

Anemia

• ●

Hookworm-like eggs that are unusually large

→ Think TRICHOSTRONGYLUS

Diagnosis

The primary diagnostic method is:

PARASITOLOGIC EXAMINATION OF STOOL

Stool microscopy demonstrates:

Characteristic nematode eggs

Egg Morphology

An important diagnostic point is that:

Trichostrongylus eggs resemble hookworm eggs

However:

TRICHOSTRONGYLUS EGGS ARE GENERALLY LARGER

This is a classic parasitology distinction.

High-Yield Egg Comparison

Trichostrongylus

→ Thin-shelled oval egg

→ Resembles hookworm

→ Usually larger

→ Often more elongated

Hookworm

→ Thin-shelled oval egg

→ Generally smaller

→ Commonly associated with Necator or Ancylostoma

Stool Identification

Species-level identification may sometimes be difficult using eggs alone because of:

Morphologic similarity among nematodes

Additional parasitologic expertise or larval identification may occasionally be required.

Treatment

The source lists:

MEBENDAZOLE

as the primary treatment.

Additional Treatment

The source also lists:

ALBENDAZOLE 400 mg orally as a single dose

as an alternative therapy.

Supportive Management

If clinically significant anemia is present, management may also include:

Assessment and correction of iron deficiency or other nutritional abnormalities

depending on the patient’s findings.

Prevention

Prevention focuses on reducing ingestion of infective larvae.

Important measures include:

• Thoroughly washing raw vegetables

• Avoiding produce contaminated with animal feces

• Good hand hygiene after handling livestock or soil

• Proper disposal of animal feces

• Improved sanitation around farms

• Veterinary parasite control in livestock

Trichostrongylus vs. Hookworm

This is the most important examination comparison.

Trichostrongylus

→ Usually acquired by ingestion

→ Associated with herbivorous livestock

→ Mild intestinal disease

→ Eggs resemble hookworm eggs but are larger

Hookworm

→ Necator americanus / Ancylostoma duodenale

→ Infective larvae usually penetrate skin

→ Ground itch

→ Pulmonary migration

→ Iron-deficiency anemia

→ Smaller hookworm-type eggs

High-Yield Distinction

Barefoot soil exposure + ground itch + anemia

→ Hookworm

Livestock exposure + contaminated vegetables + large hookworm-like eggs

→ Trichostrongylus

Trichostrongylus vs. Strongyloides

Trichostrongylus

→ Acquired by ingestion

→ Eggs may be detected in stool

→ No clinically important autoinfection cycle

Strongyloides stercoralis

→ Larvae penetrate skin

→ Larvae, rather than eggs, are usually detected in stool

→ Autoinfection can occur

→ Hyperinfection possible with immunosuppression

Trichostrongylus vs. Trichuris

Trichostrongylus

→ Hookworm-like oval eggs

→ Small-intestinal nematode

→ Livestock-associated zoonosis

Trichuris trichiura

→ Barrel/lemon-shaped eggs with bipolar plugs

→ Large-intestinal infection

→ Heavy disease may cause dysentery and rectal prolapse

High-Yield Clinical Pattern

Rural agricultural setting

• ●

Sheep/goats/cattle exposure

• ●

Mild GI symptoms ± anemia

• ●

Large hookworm-like eggs in stool

→ Think TRICHOSTRONGYLUS

Exam Essentials

Genus: Trichostrongylus

Important species: T. orientalis and T. colubriformis

Organism: Nematode helminth

Distribution: Worldwide

Major setting: Rural livestock-raising regions

Reservoir: Herbivorous animals

Transmission: Ingestion of infective larvae from contaminated vegetation/food

Typical infection: Usually asymptomatic

Symptoms: Mild dyspepsia or other GI complaints

Possible complication: Anemia

Diagnosis: Stool parasitology

Egg appearance: Similar to hookworm eggs but usually larger

Treatment: Mebendazole

Alternative: Albendazole 400 mg orally as a single dose

Prevention: Food washing, sanitation, and reduced fecal contamination from livestock

Memory Aid

TRICHOSTRONGYLUS = STRONG LIVESTOCK CONNECTION

Think:

Rural livestock

• ●

Raw contaminated vegetables

• ●

Large hookworm-like eggs

→ Trichostrongylus

And:

TRICHO-STRONG = BIGGER THAN HOOKWORM EGGS

Key clinical pearl: Trichostrongylus species are zoonotic intestinal nematodes associated with herbivorous livestock and rural environments. Most human infections are asymptomatic, but heavier infections can cause mild gastrointestinal symptoms and anemia. Diagnosis is made by stool microscopy, with the key parasitologic clue being eggs that resemble hookworm eggs but are usually larger.

Infectious Disease and Microbiology – Trichosporon beigelii

Overview

Trichosporon beigelii is a yeast-like fungus capable of forming arthroconidia, hyphae, blastoconidia, and pseudohyphae. It is best known for causing white piedra, a superficial infection of the hair shaft, but it can also produce invasive systemic infection in severely immunocompromised patients.

The organism is found in the environment, especially soil, and occurs in both tropical and temperate regions.

Classification

Genus: Trichosporon

Species: Trichosporon beigelii

Organism: Yeast-like fungus

A useful modern point is that the older name T. beigelii has historically been applied broadly, while clinically important infections are now attributed to several Trichosporon species.

Microbiologic Characteristics

Trichosporon can produce:

• Arthroconidia

• Blastoconidia

• True hyphae

• Pseudohyphae

This combination gives the organism a somewhat mixed:

Yeast + filamentous fungal appearance

High-Yield Microbiology Pattern

Yeast-like fungus

• ●

Arthroconidia

• ●

Hyphae and pseudohyphae

• ●

White hair-shaft concretions

→ Think TRICHOSPORON

Incubation Period

The incubation period is:

Unknown

Superficial infection may persist chronically before becoming clinically apparent.

Epidemiology

Trichosporon species are environmental organisms found in:

• Soil

• Water

• Organic material

They occur worldwide.

The source notes greater frequency in:

Tropical regions

although infection also occurs in:

Temperate climates

White Piedra

The classic superficial infection is:

WHITE PIEDRA

This is an infection involving the:

Hair shaft

rather than deeper skin structures.

Clinical Appearance of White Piedra

White piedra produces small:

Soft, pale, yellowish-white concretions

attached to the hair shaft.

These nodules may involve hair of the:

• Scalp

• Beard

• Mustache

• Axilla

• Pubic region

High-Yield White Piedra Pattern

Soft pale/yellow-white nodules

• ●

Hair shaft

• ●

Yeast forming arthroconidia

→ Think Trichosporon

White Piedra vs. Black Piedra

This is a classic examination comparison.

White Piedra

Organism: Trichosporon species

Nodules: Soft, white, cream, or yellowish

Hair involvement: Hair shaft

Black Piedra

Organism: Piedraia hortae

Nodules: Hard, black, firmly adherent

Memory Aid

WHITE = TRICHOSPORON

BLACK = PIEDRAIA

And:

Soft + white

→ Trichosporon

Hard + black

→ Piedraia hortae

Invasive Trichosporonosis

Although superficial disease is relatively benign, Trichosporon can cause:

SYSTEMIC INFECTION

in patients with severe impairment of host defenses.

Major Risk Groups

Invasive infection is particularly associated with:

• Hematologic malignancy

• Neutropenia

• Organ transplantation

• Advanced HIV infection

• Prolonged hospitalization

• Central venous catheters

• Broad-spectrum antibiotic exposure

Clinical Manifestations of Invasive Disease

Disseminated infection may cause:

• Fungemia

• Persistent fever

• Pulmonary infection

• Skin lesions

• Renal involvement

• Hepatic involvement

• Multiorgan dissemination

The clinical picture can resemble:

Invasive candidiasis

Skin Lesions in Disseminated Disease

Systemic trichosporonosis may produce:

Papular or nodular skin lesions

which can provide an accessible site for:

Biopsy and fungal identification

Diagnosis

The source lists:

• Culture

• Histopathology

as important diagnostic methods.

Culture

Culture can demonstrate a yeast-like fungus capable of producing:

Arthroconidia

This morphology helps distinguish Trichosporon from many other yeasts.

Histopathology

Tissue specimens may demonstrate:

• Yeast forms

• Hyphae

• Pseudohyphae

• Arthroconidia

Histopathology is especially important when evaluating:

Invasive disease

because it helps demonstrate true tissue invasion rather than colonization.

Cryptococcal Antigen Cross-Reactivity

An important diagnostic pearl from the source is:

FALSE-POSITIVE CRYPTOCOCCAL ANTIGEN TEST

Systemic Trichosporon infection can occasionally cause a false-positive result with:

Latex agglutination cryptococcal antigen testing

This occurs because of antigenic cross-reactivity.

High-Yield Diagnostic Pearl

Immunocompromised patient

• ●

Fungemia/systemic fungal infection

• ●

Positive cryptococcal antigen

but

Culture grows arthroconidia-forming yeast

→ Consider Trichosporon

Treatment of White Piedra

The source recommends:

Shaving the affected hair

followed by:

Topical azole therapy

Why Hair Removal Helps

Because the fungus colonizes and forms concretions around the:

Hair shaft

physical removal of affected hair decreases the fungal burden and improves treatment success.

Systemic Treatment

In invasive trichosporonosis, treatment requires:

SYSTEMIC ANTIFUNGAL THERAPY

The source notes that treatment data are limited.

Historically, options have included:

• Amphotericin B

• Voriconazole

Important Treatment Pearl

For invasive Trichosporon infections, azoles—particularly:

Voriconazole

are often considered important therapeutic agents.

Susceptibility can vary, so therapy should ideally be guided by:

Species identification + antifungal susceptibility + clinical severity

Amphotericin B

Although the source lists amphotericin B as potentially helpful, activity can be:

Variable

and invasive trichosporonosis can be difficult to treat.

Therefore, successful management often depends on:

• Effective systemic antifungal therapy

• Recovery from neutropenia when possible

• Removal of infected vascular devices when relevant

• Control of the underlying immunosuppressive condition

Source Control

In invasive disease, management may include:

Removal of central venous catheters

if they are suspected to be the source of fungemia.

Trichosporon vs. Candida

Both can produce yeast-like infections and pseudohyphae.

Trichosporon

→ Arthroconidia

→ White piedra

→ Invasive disease in immunocompromised hosts

→ May cause false-positive cryptococcal antigen

Candida

→ Budding yeast + pseudohyphae

→ Thrush, vaginitis, candidemia

→ Does not classically produce white piedra

Trichosporon vs. Geotrichum

Both can form:

Arthroconidia

Trichosporon

→ Arthroconidia + blastoconidia

→ White piedra

→ Opportunistic systemic infection

Geotrichum

→ Prominent rectangular arthroconidia

→ Usually lacks prominent blastoconidia

→ Rare opportunistic geotrichosis

Trichosporon vs. Piedraia hortae

Trichosporon

→ White piedra

→ Soft, pale nodules

→ Yeast-like organism

Piedraia hortae

→ Black piedra

→ Hard, black nodules

→ Dematiaceous fungus

High-Yield Clinical Pattern

Soft white/yellow hair-shaft nodules

• ●

Yeast with arthroconidia and pseudohyphae

→ Think WHITE PIEDRA due to Trichosporon

High-Yield Invasive Pattern

Neutropenic/transplant/immunocompromised patient

• ●

Persistent fungemia

• ●

Arthroconidia-forming yeast

• ●

Possible false-positive cryptococcal antigen

→ Think INVASIVE TRICHOSPORONOSIS

Exam Essentials

Genus: Trichosporon

Historical species: T. beigelii

Organism: Yeast-like fungus

Morphology: Arthroconidia + blastoconidia + hyphae + pseudohyphae

Distribution: Worldwide

Environmental reservoir: Soil and other environmental sources

Classic superficial disease: White piedra

White piedra finding: Soft yellowish-white concretions on hair shafts

Major invasive risk groups: Neutropenia, transplantation, advanced HIV, severe immunosuppression

Systemic disease: Fungemia and disseminated infection

Diagnosis: Culture + histopathology

Diagnostic pearl: May cause false-positive cryptococcal antigen testing

White piedra treatment: Shaving/removal of affected hair + topical azole

Systemic treatment: Systemic antifungal therapy, with voriconazole an important option

Source control: Consider removal of infected vascular devices

Memory Aid

TRICHOSPORON = TRICHO = HAIR

Think:

TRICHO

→ Hair

→ White concretions

→ White piedra

And:

WHITE + SOFT = TRICHOSPORON

BLACK + HARD = PIEDRAIA

Key clinical pearl: Trichosporon is an arthroconidia-forming yeast-like fungus classically associated with white piedra, producing soft pale or yellowish concretions on hair shafts. In severely immunocompromised patients it can become an invasive pathogen causing fungemia and disseminated disease. Culture and histopathology are central to diagnosis, and systemic infection can occasionally produce a false-positive cryptococcal antigen test.

Infectious Disease and Microbiology – Trichinella spiralis

Overview

Trichinella spiralis is a nematode helminth (roundworm) that causes trichinellosis, also known as trichinosis. Humans acquire infection by eating raw or inadequately cooked meat containing encysted larvae, classically pork but also meat from wild animals such as bear, wild boar, and other carnivorous or omnivorous animals.

The severity of disease depends largely on the number of larvae ingested and host factors. Many infections are asymptomatic, while heavy infections can produce a characteristic combination of gastrointestinal symptoms, fever, marked eosinophilia, periorbital edema, and diffuse myalgia.

Classification

Genus: Trichinella

Species: Trichinella spiralis

Organism: Nematode helminth (roundworm)

Disease: Trichinellosis / trichinosis

Microbiologic Characteristics

T. spiralis is a:

• Tissue-invasive nematode

• Foodborne helminth

• Parasite whose larvae become encysted in striated skeletal muscle

• Infection associated with consumption of inadequately cooked infected meat

Unlike many intestinal nematodes, the most clinically important manifestations occur when:

Larvae migrate from the intestine into skeletal muscle and other tissues.

High-Yield Microbiology Pattern

Nematode

• ●

Undercooked pork or wild-game meat

• ●

Periorbital edema

• ●

Diffuse myalgia

• ●

Marked eosinophilia

→ Think TRICHINELLA SPIRALIS

Incubation Period

The clinical course can be divided into an early:

Intestinal phase

and a later:

Systemic/muscular phase

Gastrointestinal Phase

Gastrointestinal symptoms may begin:

Within a few days after infection

after ingestion of contaminated meat.

Systemic Phase

Systemic manifestations generally develop approximately:

5–45 days after infection

as larvae disseminate and invade tissues.

Epidemiology

T. spiralis has a:

Worldwide distribution

The incidence varies according to:

• Food preparation practices

• Consumption of raw or undercooked pork

• Consumption of wild-game meat

• Animal husbandry practices

• Meat inspection and food-safety practices

Important Food Exposures

Classically associated foods include:

• Pork

• Wild boar

• Bear meat

• Other inadequately cooked wild-animal meat

The source also identifies animals such as:

Foxes

as potential wildlife reservoirs.

High-Yield Exposure Pattern

Raw/undercooked pork

or

Wild-game meat

↓

Encysted Trichinella larvae

↓

Intestinal infection

↓

Larval dissemination

↓

Skeletal muscle invasion

Life Cycle

Humans become infected by eating meat containing:

ENCYSTED LARVAE

The larvae are released during digestion.

↓

They mature into adult worms in the:

Small intestine

↓

Adult females release larvae.

↓

Larvae penetrate the intestinal mucosa.

↓

They enter the:

Bloodstream and lymphatic circulation

↓

Larvae disseminate throughout the body.

↓

They preferentially invade:

Striated skeletal muscle

↓

The larvae become established within specialized muscle cells.

Clinical Infection

The disease is called:

TRICHINELLOSIS

or:

TRICHINOSIS

Disease severity is related particularly to:

The number of larvae ingested

Heavy infections generally produce more severe systemic manifestations.

Asymptomatic Infection

Many infections are:

Asymptomatic

especially when only a small number of larvae are ingested.

Intestinal Phase

Early symptoms result from maturation of adult worms in the intestine.

Possible manifestations include:

• Diarrhea

• Abdominal discomfort

• Nausea

• Vomiting

• Malaise

The source particularly notes:

Mild diarrhea

which may precede ocular and muscular manifestations.

Systemic and Muscular Phase

As larvae disseminate into tissues, patients may develop:

• Fever

• Diffuse myalgia

• Muscle weakness

• Periorbital edema

• Facial edema

• Headache

• Marked eosinophilia

This phase is the classic presentation of symptomatic trichinellosis.

Myalgia

One of the most characteristic manifestations is:

DIFFUSE MUSCLE PAIN

Muscle invasion by larvae produces inflammation, resulting in:

Myalgia + tenderness + weakness

Muscle Distribution

Larvae preferentially involve active striated muscles.

Commonly affected muscles can include:

• Extraocular muscles

• Masseter muscles

• Diaphragm

• Intercostal muscles

• Tongue

• Deltoids

• Gastrocnemius muscles

This muscle tropism explains many of the characteristic clinical findings.

Periorbital Edema

A particularly important diagnostic clue is:

EDEMA OF THE UPPER EYELIDS

or:

PERIORBITAL EDEMA

When this occurs with:

Fever + myalgia + eosinophilia

after eating undercooked pork or wild game, trichinellosis should be strongly considered.

Classic Clinical Pattern

Undercooked pork/wild game

• ●

Early diarrhea

↓

Several days later:

Fever

• ●

Periorbital edema

• ●

Diffuse myalgia

• ●

Marked eosinophilia

→ TRICHINELLA SPIRALIS

Eosinophilia

A major laboratory clue is:

MARKED EOSINOPHILIA

Eosinophilia develops in response to:

Tissue-invasive larval migration

and can be particularly prominent during systemic disease.

Cardiac Involvement

Severe infection may involve the:

HEART

Cardiac complications can include:

• Myocarditis

• Arrhythmias

• Heart failure in severe cases

Cardiac involvement represents:

Severe trichinellosis

and requires close medical management.

Central Nervous System Involvement

The:

CENTRAL NERVOUS SYSTEM

may also be affected in severe disease.

Possible manifestations include:

• Headache

• Confusion

• Meningoencephalitis

• Seizures

• Focal neurologic abnormalities

CNS involvement is an important marker of:

Severe systemic infection

Respiratory Involvement

Because larvae can affect respiratory muscles, severe infection may produce:

• Dyspnea

• Respiratory muscle weakness

Involvement of the diaphragm and other respiratory muscles can contribute to serious complications.

Diagnosis

The source lists:

• Serology

• Muscle biopsy

as important diagnostic approaches.

A major supportive laboratory finding is:

Marked eosinophilia

Serology

Serologic testing can demonstrate:

Antibodies against Trichinella

and is useful in patients with an appropriate clinical and exposure history.

Antibodies may not become detectable immediately after infection, so timing should be considered when interpreting early negative results.

Muscle Biopsy

A muscle biopsy may demonstrate:

Encysted larvae within skeletal muscle

This can provide direct parasitologic evidence of infection.

However, biopsy is generally reserved for situations in which diagnostic uncertainty remains.

Laboratory Findings

In addition to eosinophilia, muscle inflammation may produce increased:

Muscle enzymes

such as:

Creatine kinase (CK)

in symptomatic muscular disease.

Stool Examination

An important examination point is that routine stool examination is generally:

Not useful for diagnosing trichinellosis

because the characteristic tissue phase involves larvae migrating into:

Skeletal muscle

rather than eggs being routinely passed in human stool.

Treatment

The source recommends:

MEBENDAZOLE

or:

ALBENDAZOLE

particularly when treatment is initiated:

Early in infection

Why Early Treatment Matters

Anthelmintic treatment is most useful while adult worms and developing larvae remain susceptible before extensive tissue encystment has occurred.

Therefore:

Earlier therapy is generally more effective than treatment after larvae have become established in muscle.

Corticosteroids

The source notes that:

STEROIDS

may be required when severe inflammatory manifestations occur, particularly with:

• CNS involvement

• Cardiac involvement

Corticosteroids may also be considered in other severe systemic manifestations under appropriate medical supervision.

Severe Disease Treatment Pattern

Trichinellosis

• ●

CNS or cardiac involvement

→ Albendazole/mebendazole

• ●

Corticosteroid therapy when indicated

• ●

Supportive management

Prevention

The most important preventive measure is:

PROPER COOKING OF MEAT

This applies particularly to:

• Fresh pork

• Pork products

• Bear meat

• Wild boar

• Other wild-game meat

Important Food-Safety Pearl

Do not rely solely on:

Smoking, curing, drying, or other nonvalidated preparation methods

to eliminate Trichinella larvae from wild-game meat.

Appropriate cooking is the key preventive measure.

Trichinella vs. Toxocara

Both can cause:

Eosinophilia

but their exposure patterns differ.

Trichinella spiralis

→ Undercooked meat

→ Pork/wild game

→ Intestinal symptoms followed by myalgia

→ Periorbital edema

→ Larvae in skeletal muscle

Toxocara

→ Dog/cat feces in soil

→ Children/pica

→ Visceral larva migrans

→ Hepatomegaly and pulmonary symptoms

→ Ocular larva migrans

High-Yield Distinction

Eosinophilia + myalgia + periorbital edema + undercooked pork

→ Trichinella

Eosinophilia + hepatomegaly + child + dog/cat soil exposure

→ Toxocara

Trichinella vs. Taenia saginata

Trichinella spiralis

→ Pork or wild game

→ Nematode

→ Tissue-invasive larvae

→ Myalgia + periorbital edema + eosinophilia

Taenia saginata

→ Beef

→ Cestode

→ Adult intestinal tapeworm

→ Usually mild/asymptomatic GI disease

→ Proglottids/eggs in stool

Trichinella vs. Taenia solium

Both may be associated with pork, but the diseases are very different.

Trichinella spiralis

Undercooked pork containing larvae

→ Trichinellosis

→ Muscle invasion

→ Myalgia + periorbital edema + eosinophilia

Taenia solium

Undercooked pork containing cysticerci

→ Intestinal taeniasis

Ingestion of T. solium eggs

→ Cysticercosis/neurocysticercosis

High-Yield Clinical Pattern

Undercooked pork/bear/wild-boar meat

• ●

Early gastrointestinal symptoms

↓

5–45 days later

↓

Fever + diffuse myalgia + weakness

• ●

Upper-eyelid/periorbital edema

• ●

Marked eosinophilia

→ Think TRICHINELLA SPIRALIS

Exam Essentials

Genus: Trichinella

Species: T. spiralis

Organism: Nematode helminth

Disease: Trichinellosis / trichinosis

Distribution: Worldwide

Transmission: Consumption of raw or undercooked infected meat

Classic source: Pork

Other important sources: Bear and wild-boar meat

Infective stage: Encysted larvae in meat

Early symptoms: Gastrointestinal symptoms within several days

Systemic symptoms: Approximately 5–45 days after infection

Classic systemic manifestations: Myalgia + weakness + periorbital edema

Major laboratory clue: Marked eosinophilia

Major tissue involved: Striated skeletal muscle

Serious complications: Myocarditis and CNS disease

Diagnosis: Serology and, when necessary, muscle biopsy

Stool examination: Generally not useful

Treatment: Mebendazole or albendazole, especially early in infection

Severe CNS/cardiac disease: Corticosteroids may be required

Prevention: Thoroughly cook pork and wild-game meat

Memory Aid

TRICHINELLA = TRICHY TRIAD

Think:

PORK/WILD GAME

↓

MYALGIA

• ●

PERIORBITAL EDEMA

• ●

EOSINOPHILIA

→ TRICHINELLA SPIRALIS

Another useful sequence:

GUT → BLOOD → MUSCLE

Early diarrhea

→ Larval dissemination

→ Muscle pain and edema

Key clinical pearl: Trichinella spiralis is a foodborne nematode acquired from raw or inadequately cooked pork or wild-game meat. The classic progression is early gastrointestinal illness followed days to weeks later by fever, diffuse myalgia, muscle weakness, periorbital edema, and marked eosinophilia as larvae invade skeletal muscle. Severe infections may involve the heart or CNS. Serology is an important diagnostic method, albendazole or mebendazole is most useful when given early, and proper cooking of pork and wild-game meat is the key preventive measure.

Infectious Disease and Microbiology – Treponema carateum

Overview

Treponema carateum is a spirochete that causes pinta, a chronic, nonvenereal treponemal infection involving primarily the skin. The disease occurs mainly in tropical regions of the Americas, particularly parts of Central and South America.

Pinta is characterized by slowly evolving plaque-like skin lesions that may undergo striking changes in pigmentation over time. Unlike venereal syphilis, pinta is essentially a cutaneous disease and is not classically associated with cardiovascular, neurologic, or congenital complications.

Classification

Genus: Treponema

Species: Treponema carateum

Organism: Spirochete

Disease: Pinta

Pinta belongs to the group of:

Endemic nonvenereal treponematoses

Microbiologic Characteristics

T. carateum is a:

• Thin, spiral-shaped bacterium

• Spirochete

• Treponemal organism closely related to other pathogenic Treponema species

• Primarily cutaneous pathogen

Its morphology is very similar to other pathogenic treponemes.

High-Yield Microbiology Pattern

Spirochete

• ●

Tropical Americas

• ●

Chronic plaque-like skin lesions

• ●

Progressive pigmentary changes

→ Think TREPONEMA CARATEUM

Incubation Period

The usual incubation period is approximately:

2–3 weeks

After this period, the initial skin lesion develops at the site of infection.

Epidemiology

Pinta is primarily associated with:

Tropical regions of the Americas

The source particularly emphasizes:

South America

Historically, disease has occurred in rural communities where close interpersonal contact facilitates transmission.

Transmission

Unlike syphilis, pinta is:

NONVENEREAL

Transmission is believed to occur primarily through:

Direct skin-to-skin contact with an infected lesion

especially when minor breaks in the skin permit inoculation.

Pinta

The disease caused by T. carateum is:

PINTA

Pinta is predominantly a:

Chronic cutaneous treponematosis

The disease evolves through different stages, with lesions changing in appearance and pigmentation over time.

Primary Lesion

The initial lesion is typically a:

Papule or plaque

that gradually enlarges.

The source describes plaque-like lesions particularly involving the:

• Dorsum of the foot

• Legs

Other exposed areas of skin may also become involved.

Regional Lymphadenopathy

The primary skin lesion may be accompanied by:

Regional lymph node enlargement

reflecting the local infectious process.

Evolution of Skin Lesions

As the infection progresses, additional skin lesions may appear.

One of the most characteristic features is:

ALTERED SKIN PIGMENTATION

Lesions may initially become:

Hyperpigmented

and later develop areas of:

Hypopigmentation or depigmentation

High-Yield Clinical Pattern

Tropical American exposure

• ●

Chronic plaque-like lesions

• ●

Progressive hyperpigmentation/depigmentation

• ●

No major systemic disease

→ Think PINTA

Late Pinta

Chronic disease can produce persistent:

Pigmentary abnormalities

The skin may develop irregular areas of:

• Hyperpigmentation

• Hypopigmentation

• Depigmentation

• Atrophic change in some lesions

These late pigmentary changes are among the most recognizable features of pinta.

Systemic Involvement

An important distinction from syphilis is that pinta is primarily limited to the:

SKIN

It does not characteristically produce the severe:

• Neurologic

• Cardiovascular

• Visceral

• Congenital

manifestations associated with Treponema pallidum syphilis.

Diagnosis

Diagnosis is based on:

• Clinical presentation

• Epidemiologic history

• Treponemal and nontreponemal serology

• Direct demonstration of treponemes from active lesions

Nontreponemal Serologic Tests

The source lists:

Rapid Plasma Reagin (RPR)

and:

Venereal Disease Research Laboratory (VDRL)

testing.

These tests may become reactive in pinta.

Treponemal Serologic Tests

Treponemal tests may also be positive, including:

Treponema pallidum particle agglutination (TPPA)

Important Serology Pearl

Standard syphilis serologic tests generally:

Cannot reliably distinguish pinta from other treponemal infections

because the pathogenic treponemes are antigenically very similar.

Therefore, diagnosis depends on:

Clinical syndrome + epidemiology + serology

rather than serology alone.

Dark-Field Examination

The source also lists:

DARK-FIELD MICROSCOPY

Material obtained from an active lesion can be examined for:

Motile spirochetes

However, the organisms are morphologically difficult to distinguish from other pathogenic treponemes.

Diagnostic Pattern

Typical chronic pigmentary skin lesions

• ●

Residence/travel in endemic tropical Americas

• ●

Reactive treponemal serology

±

Spirochetes demonstrated in lesion material

→ Supports PINTA

Treatment

The source identifies:

BENZYL PENICILLIN

as the primary treatment.

Treponemal infections are generally highly susceptible to:

Penicillin

Additional Treatment

The source lists:

• Tetracycline

• Chloramphenicol

as additional therapeutic options.

Penicillin remains the classic treatment when appropriate.

Effect of Treatment

Antimicrobial treatment:

Eradicates the infection

and prevents further progression.

However, longstanding pigmentary changes may:

Resolve slowly or remain persistent

even after successful antimicrobial therapy.

Pinta vs. Syphilis vs. Yaws vs. Bejel

The endemic treponematoses are an important examination comparison.

Pinta

Organism: T. carateum

Distribution: Tropical Americas

Major manifestation: Pigmentary skin disease

Systemic disease: Minimal/absent

Yaws

Organism: T. pallidum subsp. pertenue

Distribution: Humid tropical regions

Major manifestations: Skin, soft tissue, and bone disease

Bejel

Organism: T. pallidum subsp. endemicum

Distribution: Traditionally arid regions

Major manifestations: Mucocutaneous and skeletal disease

Syphilis

Organism: T. pallidum subsp. pallidum

Transmission: Primarily sexual or vertical

Major manifestations: Multistage systemic disease with potential neurologic, cardiovascular, and congenital involvement

High-Yield Comparison

Pinta

→ Pigment

Yaws

→ Skin + bone

Bejel

→ Mucosa + bone

Syphilis

→ Sexual/systemic treponematosis

Prevention

Prevention focuses on:

• Early identification and treatment of infected individuals

• Reducing direct contact with active lesions

• Improving hygiene and living conditions in endemic communities

• Treating cases to interrupt community transmission

High-Yield Clinical Pattern

Tropical South/Central America

• ●

2–3 week incubation

• ●

Plaque-like lesion on extremity

• ●

Regional lymphadenopathy

• ●

Progressive pigmentary changes

→ Think TREPONEMA CARATEUM → PINTA

Exam Essentials

Genus: Treponema

Species: T. carateum

Organism: Spirochete

Disease: Pinta

Disease category: Nonvenereal endemic treponematosis

Incubation: Usually 2–3 weeks

Distribution: Primarily tropical Americas

Transmission: Primarily direct skin contact with infectious lesions

Major organ involved: Skin

Primary lesion: Papule/plaque, often involving the extremities

Lymph nodes: Regional lymphadenopathy may occur

Classic late feature: Hyperpigmentation followed by hypopigmentation/depigmentation

Major systemic complications: Generally absent

Diagnosis: Clinical/epidemiologic findings + RPR/VDRL and treponemal testing

Direct examination: Dark-field microscopy of active lesions

Serology pearl: Standard tests cannot reliably distinguish the different treponematoses

Classic treatment: Benzyl penicillin

Additional source treatments: Tetracycline or chloramphenicol

Memory Aid

PINTA = PAINTED SKIN

Think:

PINTA

→ PIGMENT

→ PAINTED appearance of the skin

And:

T. CARATEUM = CUTANEOUS TREPONEME

Tropical Americas + chronic pigment-changing skin plaques

→ T. carateum

Key clinical pearl: Treponema carateum is the spirochete responsible for pinta, a nonvenereal endemic treponematosis of tropical America characterized primarily by chronic plaque-like skin lesions that develop progressive hyperpigmentation and depigmentation. Treponemal and nontreponemal serologic tests may be reactive but cannot reliably distinguish pinta from other treponematoses, so the clinical and epidemiologic setting is essential. Penicillin is the classic treatment.

Infectious Disease and Microbiology – Toxocara Species

Overview

Toxocara species are nematode helminths that cause human toxocariasis, usually after ingestion of embryonated eggs from soil contaminated with dog or cat feces. The two major species are Toxocara canis from dogs and Toxocara cati from cats.

Humans are accidental hosts. The larvae migrate through tissues but do not normally mature into adult worms, producing syndromes such as visceral larva migrans and ocular larva migrans.

Classification

Genus: Toxocara

Important species:

• Toxocara canis — associated with dogs

• Toxocara cati — associated with cats

Organism: Nematode helminth

Human disease: Toxocariasis

Microbiologic Characteristics

Toxocara species are:

• Roundworms

• Nematode helminths

• Parasites of dogs and cats

• Transmitted to humans through ingestion of infective eggs

• Unable to complete their normal life cycle in humans

Humans therefore serve as:

Accidental/paratenic hosts

High-Yield Microbiology Pattern

Nematode

• ●

Dog or cat feces

• ●

Contaminated soil

• ●

Larval migration through human tissues

→ Think TOXOCARA

Transmission

The major route of infection is:

INGESTION OF EMBRYONATED EGGS

Eggs are shed in the feces of infected:

Dogs — T. canis

or

Cats — T. cati

After a period in the environment, the eggs become infective.

Soil Exposure

Humans typically acquire infection by ingesting:

Soil contaminated with dog or cat feces

Risk is increased by:

• Poor hand hygiene

• Playing in contaminated soil

• Geophagia or pica

• Exposure to contaminated sandboxes

• Close contact with infected puppies or kittens

Young Children

Young children are particularly susceptible because they are more likely to:

• Play directly in soil

• Put contaminated hands or objects in the mouth

• Practice geophagia or pica

• Have close contact with puppies or kittens

High-Yield Epidemiologic Pattern

Young child

• ●

Pica/soil exposure

• ●

Dogs or cats

• ●

Marked eosinophilia

→ Think Toxocara

Incubation Period

Clinical manifestations may develop:

Weeks to months after infection

However, ocular disease may become apparent much later.

The source notes that ocular manifestations may appear approximately:

2–10 years after initial infection

Life Cycle in Humans

After ingestion:

Embryonated egg

↓

Larva hatches in the intestine

↓

Penetrates intestinal wall

↓

Enters bloodstream

↓

Migrates through tissues

↓

Inflammatory and eosinophilic response develops

Because humans are accidental hosts:

Larvae do not mature into normal adult intestinal worms

Major Clinical Syndromes

The two classic forms are:

VISCERAL LARVA MIGRANS

and

OCULAR LARVA MIGRANS

Visceral Larva Migrans

Visceral larva migrans results from migration of larvae through internal organs.

Many infections are:

Mild or asymptomatic

but symptomatic disease may produce:

• Fever

• Malaise

• Hepatomegaly

• Abdominal symptoms

• Cough

• Wheezing

Hepatic Involvement

The liver is one of the most common organs involved.

Patients may develop:

Hepatomegaly

and occasionally abnormal liver-related findings.

The liver may contain inflammatory lesions around migrating larvae.

Pulmonary Involvement

Larval migration through the lungs can cause:

• Cough

• Wheezing

• Dyspnea

• Pulmonary infiltrates in some cases

The combination of:

Pulmonary symptoms + eosinophilia + dog/cat soil exposure

is highly suggestive of a tissue-migrating helminth such as Toxocara.

Eosinophilia

One of the most characteristic findings in visceral toxocariasis is:

MARKED EOSINOPHILIA

The source notes that eosinophil counts in heavy infection may rise dramatically, even to approximately:

80,000/mm³

High-Yield Visceral Pattern

Young child

• ●

Dog/cat exposure

• ●

Fever

• ●

Hepatomegaly

• ●

Cough/wheezing

• ●

Marked eosinophilia

→ Think VISCERAL LARVA MIGRANS due to Toxocara

Ocular Larva Migrans

When a larva migrates into the eye, the condition is called:

OCULAR LARVA MIGRANS

This form may occur years after initial infection.

Ocular Manifestations

Possible findings include:

• Reduced visual acuity

• Unilateral visual disturbance

• Retinal granuloma

• Uveitis

• Endophthalmitis-like inflammation

• Strabismus in some children

Ocular disease may cause significant permanent visual impairment if not recognized.

Important Ocular Pearl

Unlike visceral disease, ocular toxocariasis often does not produce the same degree of:

Marked peripheral eosinophilia

Therefore, a normal eosinophil count does not exclude:

Ocular larva migrans

CNS Disease

Rarely, larvae may migrate to the:

Central nervous system

producing neurologic toxocariasis.

Possible manifestations depend on the involved site and may include:

• Headache

• Seizures

• Focal neurologic findings

Diagnosis

Diagnosis is based primarily on:

• Clinical presentation

• Epidemiologic exposure

• Serologic testing such as ELISA

ELISA

Serologic testing by:

ELISA

can detect antibodies against Toxocara antigens and is an important diagnostic tool.

Interpretation should take into account:

Compatible clinical findings + exposure history

because antibodies can indicate previous exposure as well as active disease.

Tissue Biopsy

Direct visualization of larvae in:

Tissue biopsy

can establish a definitive diagnosis.

However, the source emphasizes that biopsy is:

Rarely indicated

because larvae are difficult to locate and diagnosis is usually made clinically and serologically.

Stool Examination

An important exam point is:

STOOL EXAMINATION IS NOT USEFUL FOR HUMAN TOXOCARIASIS

Why?

Because humans do not usually harbor:

Adult intestinal Toxocara worms

Therefore, humans do not typically pass:

Toxocara eggs in stool

High-Yield Diagnostic Pattern

Visceral symptoms

• ●

Marked eosinophilia

• ●

Dog/cat soil exposure

• ●

Positive Toxocara ELISA

→ TOXOCARIASIS

Treatment

Many infections are:

Mild and self-limited

Therefore, the source notes that:

No treatment is usually necessary

for uncomplicated mild disease.

Albendazole

For:

Heavy, symptomatic, or significant visceral infection

the source recommends:

ALBENDAZOLE

Albendazole is a commonly used antihelminthic agent for clinically important toxocariasis.

Ocular Disease

Suspected ocular involvement requires:

OPHTHALMOLOGY EVALUATION

because visual injury can become permanent.

Management may require individualized treatment directed at both:

The parasite

and

The inflammatory response within the eye

Why Ophthalmology Matters

In ocular toxocariasis, much of the damage may result from:

Host inflammatory response around the larva

Therefore, treatment decisions require careful ophthalmologic assessment to preserve vision.

Toxocara vs. Ascaris

Both are nematodes, but:

Toxocara

→ Dog/cat parasite

→ Humans are accidental hosts

→ Tissue larvae

→ Visceral/ocular larva migrans

→ Marked eosinophilia

→ No adult worms or eggs in human stool

Ascaris lumbricoides

→ Human intestinal nematode

→ Adults live in intestine

→ Eggs are passed in human stool

→ Pulmonary larval migration can occur

Toxocara vs. Ancylostoma braziliense

Both can produce larval migration in humans.

Toxocara

→ Visceral or ocular larva migrans

→ Internal organs/eye

→ Dog/cat fecal contamination

→ Often marked eosinophilia

Ancylostoma braziliense

→ Cutaneous larva migrans

→ Serpiginous pruritic skin tracks

→ Dog/cat hookworm larvae penetrate skin

Toxocara vs. Strongyloides

Toxocara

→ Acquired by ingesting eggs

→ Tissue migration

→ Humans do not develop adult intestinal egg-producing infection

→ Visceral/ocular larva migrans

Strongyloides

→ Infective larvae penetrate skin

→ Adult worms inhabit intestine

→ Autoinfection can occur

→ Hyperinfection in immunosuppression

Prevention

Prevention focuses on reducing exposure to infective eggs.

Important measures include:

• Regular veterinary deworming of dogs and cats

• Prompt disposal of pet feces

• Handwashing after soil or animal contact

• Preventing children from eating soil

• Covering sandboxes when not in use

• Washing produce contaminated with soil

• Preventing pets from defecating in children’s play areas

High-Yield Clinical Pattern

Young child

• ●

Soil ingestion/pica

• ●

Dog or cat exposure

• ●

Fever + hepatomegaly + cough/wheezing

• ●

Extreme eosinophilia

→ Think TOXOCARA → VISCERAL LARVA MIGRANS

High-Yield Ocular Pattern

Child or young person

• ●

Unilateral visual problem

• ●

Retinal granuloma

• ●

Remote dog/cat/soil exposure

→ Think OCULAR LARVA MIGRANS due to Toxocara

Exam Essentials

Genus: Toxocara

Species: T. canis and T. cati

Organism: Nematode helminth

Dog-associated species: T. canis

Cat-associated species: T. cati

Distribution: Worldwide

Transmission: Ingestion of embryonated eggs from soil contaminated with dog/cat feces

Major risk group: Young children, especially with pica/geophagia

Incubation: Weeks to months

Ocular disease latency: May appear 2–10 years later

Major syndrome: Visceral larva migrans

Classic visceral findings: Fever, malaise, hepatomegaly, cough, and wheezing

Major laboratory clue: Marked eosinophilia

Eye disease: Ocular larva migrans

Diagnosis: Clinical findings + ELISA

Definitive but rarely needed: Larva in tissue biopsy

Stool examination: Usually not diagnostic because humans do not harbor adult egg-producing worms

Mild infection: Often no treatment required

Heavy/symptomatic infection: Albendazole

Ocular involvement: Urgent ophthalmologic evaluation

Memory Aid

TOXOCARA = TODDLER + TOY SOIL + TOXIC EOSINOPHILIA

Think:

Toddler playing in contaminated soil

• ●

Dog/cat feces

• ●

Huge eosinophilia

• ●

Liver/lung symptoms

→ Toxocara

And:

CANIS = CANINE

T. canis → dogs

CATI = CAT

T. cati → cats

Key clinical pearl: Toxocara canis and T. cati cause toxocariasis when humans accidentally ingest embryonated eggs from soil contaminated with dog or cat feces. Children are especially vulnerable. Visceral larva migrans classically produces hepatomegaly, pulmonary symptoms, and striking eosinophilia, whereas ocular larva migrans may present years later with unilateral retinal disease and may occur without marked eosinophilia. Because humans harbor migrating larvae rather than adult intestinal worms, stool examination is not useful; diagnosis relies mainly on exposure history, clinical findings, and serology.